These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20206692)

  • 1. Down-regulation of NF-kappaB signals is involved in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.
    Bao BY; Ting HJ; Hsu JW; Yasmin-Karim S; Messing E; Lee YF
    J Steroid Biochem Mol Biol; 2010 May; 120(1):11-21. PubMed ID: 20206692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
    Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
    Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.
    Ting HJ; Bao BY; Reeder JE; Messing EM; Lee YF
    Mol Cancer Res; 2007 Sep; 5(9):967-80. PubMed ID: 17855664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor.
    Sun J; Kong J; Duan Y; Szeto FL; Liao A; Madara JL; Li YC
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E315-22. PubMed ID: 16507601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines.
    Zhuang SH; Schwartz GG; Cameron D; Burnstein KL
    Mol Cell Endocrinol; 1997 Jan; 126(1):83-90. PubMed ID: 9027366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
    Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
    Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naïve B cells.
    Geldmeyer-Hilt K; Heine G; Hartmann B; Baumgrass R; Radbruch A; Worm M
    Biochem Biophys Res Commun; 2011 Apr; 407(4):699-702. PubMed ID: 21420936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
    Lu X; Farmer P; Rubin J; Nanes MS
    J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.
    Chang PL; Lee TF; Garretson K; Prince CW
    Clin Exp Metastasis; 1997 Nov; 15(6):580-92. PubMed ID: 9344042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of EGR-1 modulates the activity of NF-κB and AP-1 in prostate carcinoma PC-3 and LNCaP cell lines.
    Parra E; Ferreira J; Ortega A
    Int J Oncol; 2011 Aug; 39(2):345-52. PubMed ID: 21617851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
    Banwell CM; MacCartney DP; Guy M; Miles AE; Uskokovic MR; Mansi J; Stewart PM; O'Neill LP; Turner BM; Colston KW; Campbell MJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2004-13. PubMed ID: 16609009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental study on 1,25(OH)
    Du J; Li R; Yu F; Yang F; Wang J; Chen Q; Wang X; Zhao B; Zhang F
    Oral Dis; 2017 Sep; 23(6):770-778. PubMed ID: 28231625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis.
    Bao BY; Yao J; Lee YF
    Carcinogenesis; 2006 Sep; 27(9):1883-93. PubMed ID: 16624828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
    Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
    Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.
    Kim JS; Roberts JM; Bingman WE; Shao L; Wang J; Ittmann MM; Weigel NL
    Endocrinology; 2014 Sep; 155(9):3262-73. PubMed ID: 24926821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
    Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
    Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-dihydroxyvitamin D3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells.
    Huang YC; Hung WC
    J Cell Physiol; 2006 Nov; 209(2):363-9. PubMed ID: 16883603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1α,25-dihydroxyvitamin D3 inhibits cell growth and NFκB signaling in tamoxifen-resistant breast cancer cells.
    Lundqvist J; Yde CW; Lykkesfeldt AE
    Steroids; 2014 Jul; 85():30-5. PubMed ID: 24747771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.